Loading…

Memory improvement following induced hyperinsulinemia in alzheimer's disease

Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated w...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of aging 1996, Vol.17 (1), p.123-130
Main Authors: Craft, Suzanne, Newcomer, John, Kanne, Stephen, Dagogo-Jack, Samuel, Cryer, Philip, Sheline, Yvette, Luby, Joan, Dagogo-Jack, Agbani, Alderson, Amy
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813
cites cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813
container_end_page 130
container_issue 1
container_start_page 123
container_title Neurobiology of aging
container_volume 17
creator Craft, Suzanne
Newcomer, John
Kanne, Stephen
Dagogo-Jack, Samuel
Cryer, Philip
Sheline, Yvette
Luby, Joan
Dagogo-Jack, Agbani
Alderson, Amy
description Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.
doi_str_mv 10.1016/0197-4580(95)02002-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78084464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0197458095020020</els_id><sourcerecordid>15616728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</originalsourceid><addsrcrecordid>eNqFkMtuE0EQRVuIyDiBPyDSLBAhi4Gqdj83SMgCEskRG1i3enpqkkbzMN0eR87XM8aWl2RVi3vuVekw9hbhIwKqT4BWl0Ia-GDlNXAAXsILNkcpTYnC6pdsfkJesfOcfwOAFlrN2Mxoo7QVc7a6o25IuyJ26zRsqaN-UzRD2w6Psb8vYl-PgeriYbemFPs8trGnLvopKHz79ECxo3SVizpm8ples7PGt5neHO8F-_Xt68_lTbn68f12-WVVBmEWm1JiLa2scGG5hhp0HbAKwldKe7SVCgoRuOa88joIHRprZFNZaDhKC8Hg4oK9P-xOP_8ZKW9cF3OgtvU9DWN22oARQolnQZQKleZmAsUBDGnIOVHj1il2Pu0cgtvbdnuVbq_SWen-2XYw1S6P-2PVUX0qHfVO-btj7nPwbZN8H2I-YdwqY62asM8HjCZp20jJ5RCpn8zHRGHj6iH-_4-_GYGbCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15616728</pqid></control><display><type>article</type><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><source>ScienceDirect Journals</source><creator>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</creator><creatorcontrib>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</creatorcontrib><description>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</description><identifier>ISSN: 0197-4580</identifier><identifier>EISSN: 1558-1497</identifier><identifier>DOI: 10.1016/0197-4580(95)02002-0</identifier><identifier>PMID: 8786794</identifier><identifier>CODEN: NEAGDO</identifier><language>eng</language><publisher>London: Elsevier Inc</publisher><subject>Aged ; Alzheimer Disease - metabolism ; Alzheimer Disease - physiopathology ; Alzheimer Disease - psychology ; Alzheimer's disease ; Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Fatty Acids - blood ; Glucagon - blood ; Humans ; Hyperglycemia - blood ; Hyperinsulinemia ; Hyperinsulinism - metabolism ; Lactates - blood ; Medical sciences ; Memory ; Memory - physiology ; Neurology ; Norepinephrine - blood ; Psychiatric Status Rating Scales</subject><ispartof>Neurobiology of aging, 1996, Vol.17 (1), p.123-130</ispartof><rights>1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</citedby><cites>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2968996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8786794$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Craft, Suzanne</creatorcontrib><creatorcontrib>Newcomer, John</creatorcontrib><creatorcontrib>Kanne, Stephen</creatorcontrib><creatorcontrib>Dagogo-Jack, Samuel</creatorcontrib><creatorcontrib>Cryer, Philip</creatorcontrib><creatorcontrib>Sheline, Yvette</creatorcontrib><creatorcontrib>Luby, Joan</creatorcontrib><creatorcontrib>Dagogo-Jack, Agbani</creatorcontrib><creatorcontrib>Alderson, Amy</creatorcontrib><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><title>Neurobiology of aging</title><addtitle>Neurobiol Aging</addtitle><description>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</description><subject>Aged</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer Disease - psychology</subject><subject>Alzheimer's disease</subject><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Fatty Acids - blood</subject><subject>Glucagon - blood</subject><subject>Humans</subject><subject>Hyperglycemia - blood</subject><subject>Hyperinsulinemia</subject><subject>Hyperinsulinism - metabolism</subject><subject>Lactates - blood</subject><subject>Medical sciences</subject><subject>Memory</subject><subject>Memory - physiology</subject><subject>Neurology</subject><subject>Norepinephrine - blood</subject><subject>Psychiatric Status Rating Scales</subject><issn>0197-4580</issn><issn>1558-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkMtuE0EQRVuIyDiBPyDSLBAhi4Gqdj83SMgCEskRG1i3enpqkkbzMN0eR87XM8aWl2RVi3vuVekw9hbhIwKqT4BWl0Ia-GDlNXAAXsILNkcpTYnC6pdsfkJesfOcfwOAFlrN2Mxoo7QVc7a6o25IuyJ26zRsqaN-UzRD2w6Psb8vYl-PgeriYbemFPs8trGnLvopKHz79ECxo3SVizpm8ples7PGt5neHO8F-_Xt68_lTbn68f12-WVVBmEWm1JiLa2scGG5hhp0HbAKwldKe7SVCgoRuOa88joIHRprZFNZaDhKC8Hg4oK9P-xOP_8ZKW9cF3OgtvU9DWN22oARQolnQZQKleZmAsUBDGnIOVHj1il2Pu0cgtvbdnuVbq_SWen-2XYw1S6P-2PVUX0qHfVO-btj7nPwbZN8H2I-YdwqY62asM8HjCZp20jJ5RCpn8zHRGHj6iH-_4-_GYGbCA</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Craft, Suzanne</creator><creator>Newcomer, John</creator><creator>Kanne, Stephen</creator><creator>Dagogo-Jack, Samuel</creator><creator>Cryer, Philip</creator><creator>Sheline, Yvette</creator><creator>Luby, Joan</creator><creator>Dagogo-Jack, Agbani</creator><creator>Alderson, Amy</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><author>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Aged</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer Disease - psychology</topic><topic>Alzheimer's disease</topic><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Fatty Acids - blood</topic><topic>Glucagon - blood</topic><topic>Humans</topic><topic>Hyperglycemia - blood</topic><topic>Hyperinsulinemia</topic><topic>Hyperinsulinism - metabolism</topic><topic>Lactates - blood</topic><topic>Medical sciences</topic><topic>Memory</topic><topic>Memory - physiology</topic><topic>Neurology</topic><topic>Norepinephrine - blood</topic><topic>Psychiatric Status Rating Scales</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Craft, Suzanne</creatorcontrib><creatorcontrib>Newcomer, John</creatorcontrib><creatorcontrib>Kanne, Stephen</creatorcontrib><creatorcontrib>Dagogo-Jack, Samuel</creatorcontrib><creatorcontrib>Cryer, Philip</creatorcontrib><creatorcontrib>Sheline, Yvette</creatorcontrib><creatorcontrib>Luby, Joan</creatorcontrib><creatorcontrib>Dagogo-Jack, Agbani</creatorcontrib><creatorcontrib>Alderson, Amy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neurobiology of aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Craft, Suzanne</au><au>Newcomer, John</au><au>Kanne, Stephen</au><au>Dagogo-Jack, Samuel</au><au>Cryer, Philip</au><au>Sheline, Yvette</au><au>Luby, Joan</au><au>Dagogo-Jack, Agbani</au><au>Alderson, Amy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Memory improvement following induced hyperinsulinemia in alzheimer's disease</atitle><jtitle>Neurobiology of aging</jtitle><addtitle>Neurobiol Aging</addtitle><date>1996</date><risdate>1996</risdate><volume>17</volume><issue>1</issue><spage>123</spage><epage>130</epage><pages>123-130</pages><issn>0197-4580</issn><eissn>1558-1497</eissn><coden>NEAGDO</coden><abstract>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</abstract><cop>London</cop><pub>Elsevier Inc</pub><pmid>8786794</pmid><doi>10.1016/0197-4580(95)02002-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0197-4580
ispartof Neurobiology of aging, 1996, Vol.17 (1), p.123-130
issn 0197-4580
1558-1497
language eng
recordid cdi_proquest_miscellaneous_78084464
source ScienceDirect Journals
subjects Aged
Alzheimer Disease - metabolism
Alzheimer Disease - physiopathology
Alzheimer Disease - psychology
Alzheimer's disease
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Fatty Acids - blood
Glucagon - blood
Humans
Hyperglycemia - blood
Hyperinsulinemia
Hyperinsulinism - metabolism
Lactates - blood
Medical sciences
Memory
Memory - physiology
Neurology
Norepinephrine - blood
Psychiatric Status Rating Scales
title Memory improvement following induced hyperinsulinemia in alzheimer's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A36%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Memory%20improvement%20following%20induced%20hyperinsulinemia%20in%20alzheimer's%20disease&rft.jtitle=Neurobiology%20of%20aging&rft.au=Craft,%20Suzanne&rft.date=1996&rft.volume=17&rft.issue=1&rft.spage=123&rft.epage=130&rft.pages=123-130&rft.issn=0197-4580&rft.eissn=1558-1497&rft.coden=NEAGDO&rft_id=info:doi/10.1016/0197-4580(95)02002-0&rft_dat=%3Cproquest_cross%3E15616728%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15616728&rft_id=info:pmid/8786794&rfr_iscdi=true